So it has been a mystery, until now why drugs that are coming on the market adressing plaques in Alzheimer's do not work. It turna out that the original studies done 16 years ago may have been fraudulent.
This obviously is important for comapnies that are betting on their next release to be a big thing especially after their last one was a flop(I am looking at you Biogen).
What bothers me is that people in the field obviously know this so why keep pursuing it and basically committing fraud?
Here is a link to the article describing this:
Leave a Reply